Chapter 21: Management of Patients with Chronic Pulmonary Disease

Overview and Definition

Chronic Obstructive Pulmonary Disease (COPD) is a preventable, treatable, and slowly progressive respiratory disease characterized by airflow obstruction in the airways and pulmonary parenchyma. The airflow limitation is not fully reversible and includes diseases such as emphysema and chronic bronchitis. Asthma can coexist with COPD and is a risk factor for its development. COPD is a leading cause of morbidity and mortality worldwide.

• Key Features: Airflow obstruction, chronic inflammation, progressive symptoms

• Major Types: Emphysema, Chronic Bronchitis

• Other Related Disorders: Cystic fibrosis, bronchiectasis, asthma

Pathophysiology of COPD

The pathophysiology of COPD involves a progressive limitation of airflow due to an abnormal inflammatory response to noxious particles or gases. Chronic inflammation leads to structural changes in the airways, including increased goblet cells, mucus gland hyperplasia, and fibrosis. Proteinase-antiproteinase imbalance contributes to lung tissue destruction.

• Chronic Bronchitis: Inflammation, increased mucus glands, excess mucus, and airway narrowing.

• Emphysema: Destruction of alveolar walls, loss of elastic recoil, and air trapping.

Figure: Comparison of normal bronchus and chronic bronchitis showing inflammation, increased mucus glands, and excess mucus production.

Risk Factors for COPD

• Cigarette Smoking: Most significant risk factor

• Environmental Exposures: Occupational dusts, chemicals, air pollution

• Genetic Factors: Alpha1-antitrypsin deficiency

• Other: Age, prior infections, lower socioeconomic status

Clinical Manifestations of COPD

• Primary Symptoms: Chronic cough, sputum production, dyspnea

• Advanced Disease: Dyspnea at rest, weight loss, barrel chest, retraction of supraclavicular fossae

Figure: Comparison of normal chest wall and barrel-shaped chest of emphysema, illustrating increased anterior-posterior diameter.

Assessment and Diagnostic Findings

• History and Physical Exam: Exposure to risk factors, symptom progression

• Pulmonary Function Tests: Spirometry to confirm airflow obstruction

• Imaging: Chest x-ray, high-resolution CT scan

• Laboratory: Arterial blood gases, screening for alpha1-antitrypsin deficiency

Complications of COPD

• Respiratory Insufficiency and Failure

• Pneumonia, Chronic Atelectasis, Pneumothorax

• Pulmonary Arterial Hypertension (Cor Pulmonale)

Medical and Pharmacologic Management of COPD

Management focuses on risk reduction, symptom control, and prevention of exacerbations.

• Smoking Cessation: Most cost-effective intervention

• Oxygen Therapy: For hypoxemia

• Pharmacologic Therapy: Bronchodilators, inhaled corticosteroids, combination therapies

Table: Select bronchodilator medications for COPD, including beta2-agonists, anticholinergics, and combination agents.

Nursing Management of COPD

• Educate patients about disease, progression, and treatment

• Monitor for dyspnea, hypoxemia, and complications

• Promote airway clearance: directed coughing, chest physiotherapy, increased fluid intake

Figure: High-frequency chest wall oscillation vest used for airway clearance in COPD management.

Oxygen Therapy in COPD

Oxygen therapy is used to treat hypoxemia and improve quality of life. Various delivery devices are selected based on patient needs and oxygen requirements.

Figures: Oxygen delivery devices and patient education points for safe and effective oxygen therapy.

Bronchiectasis

Overview and Pathophysiology

Bronchiectasis is a chronic, irreversible dilation of the bronchi and bronchioles due to destruction of muscle and elastic tissue, often following recurrent infections or conditions such as cystic fibrosis. The disease is characterized by impaired mucociliary clearance, retention of secretions, and progressive respiratory insufficiency.

• Key Features: Chronic cough, copious purulent sputum, hemoptysis, clubbing of fingers

• Diagnosis: High-resolution CT scan showing bronchial dilation

Medical and Nursing Management of Bronchiectasis

• Promote bronchial drainage and clear secretions (chest physiotherapy, postural drainage)

• Prevent/control infection (antibiotics based on sensitivity studies)

• Smoking cessation is critical

• Energy conservation and nutritional support

Asthma

Overview and Pathophysiology

Asthma is a heterogeneous disease characterized by chronic airway inflammation, airway hyperresponsiveness, mucosal edema, and mucus production. Symptoms include recurrent episodes of cough, chest tightness, wheezing, and dyspnea. Asthma is largely reversible with treatment.

• Triggers: Allergens, exercise, infections, weather changes

• Inflammatory Cells: Mast cells, macrophages, T lymphocytes, neutrophils, eosinophils

• Mediators: Histamine, bradykinin, leukotrienes

Figure: Pathophysiology of asthma and COPD, showing inflammation, airway hyperresponsiveness, and airflow limitation.

Clinical Manifestations and Diagnosis of Asthma

• Symptoms: Cough, chest tightness, dyspnea, wheezing (often nocturnal or early morning)

• Diagnosis: Episodic symptoms, partial reversibility, family history, environmental factors

Prevention and Complications of Asthma

• Identify and avoid triggers (dust, mites, pets, molds, pollens)

• Complications: Status asthmaticus, respiratory failure, pneumonia, atelectasis

Medical and Pharmacologic Management of Asthma

• Prevent lung function impairment and exacerbations

• Quick-relief medications (SABAs, anticholinergics) for acute symptoms

• Long-acting medications (corticosteroids, LABAs, LAMAs, leukotriene modifiers, immunomodulators) for persistent asthma

Peak Flow Monitoring in Asthma

Peak flow monitoring measures the highest airflow during forced expiration and is used to assess asthma severity and control. It helps in early detection of exacerbations and guides self-management.

Figure: Patient education chart for proper use of peak flow meter in asthma management.

Nursing Management and Patient Education in Asthma

• Assess respiratory status, monitor symptoms, and administer medications

• Educate patients on disease nature, medication use, triggers, inhalation technique, and action plans

• Promote adherence to therapy and follow-up care

Status Asthmaticus

Overview and Pathophysiology

Status asthmaticus is a severe, life-threatening asthma exacerbation unresponsive to conventional therapy. It is characterized by severe bronchospasm, mucus plugging, and ventilation-perfusion abnormalities leading to hypoxemia and respiratory failure.

• Clinical Manifestations: Labored breathing, prolonged exhalation, distended neck veins, wheezing (may disappear as obstruction worsens)

• Assessment: General and physical assessment, laboratory evaluation (ABGs, pulse oximetry)

Medical and Nursing Management of Status Asthmaticus

• Close monitoring and objective reevaluation

• Initial treatment: SABA (albuterol), systemic corticosteroids, supplemental oxygen, IV fluids

• Magnesium sulfate for severe cases

• Continuous monitoring, fluid management, and energy conservation

Cystic Fibrosis

Overview and Pathophysiology

Cystic fibrosis (CF) is the most common fatal autosomal recessive disease among White Americans, caused by mutations in the CFTR protein. This leads to thick, viscous secretions in the lungs, pancreas, and other organs, resulting in chronic respiratory infections and multi-organ involvement.

• Key Features: Bronchial mucus plugging, inflammation, bronchiectasis

• Common Mutation: F508 (over 2000 mutations identified)

Clinical Manifestations and Diagnosis of Cystic Fibrosis

• Pulmonary: Productive cough, wheezing, hyperinflation, chronic infection

• Non-pulmonary: Pancreatic insufficiency, recurrent pancreatitis, weight loss, diabetes, infertility

• Diagnosis: Clinical picture and laboratory evidence of CFTR dysfunction

Medical and Nursing Management of Cystic Fibrosis

• Multimodal antibiotic regimens, airway clearance, bronchodilators, CFTR modulators, nutritional support

• Promote removal of secretions (CPT, postural drainage, chest percussion)

• Prevent infections, educate on early signs, and provide nutritional counseling